|
1
|
Bohensky J, Terkhorn SP, Freeman TA, Adams
CS, Garcia JA, Shapiro IM and Srinivas V: Regulation of autophagy
in human and murine cartilage: Hypoxia-inducible factor 2
suppresses chondrocyte autophagy. Arthritis Rheum. 60:1406–1415.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mole DR, Blancher C, Copley RR, Pollard
PJ, Gleadle JM, Ragoussis J and Ratcliffe PJ: Genome-wide
association of hypoxia-inducible factor (HIF)-1α and HIF-2α DNA
binding with expression profiling of hypoxia-inducible transcripts.
J Biol Chem. 284:16767–16775. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kütscher C, Lampert FM, Kunze M,
Markfeld-Erol F, Stark GB and Finkenzeller G: Overexpression of
hypoxia-inducible factor-1 alpha improves vasculogenesis-related
functions of endothelial progenitor cells. Microvasc Res.
105:85–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rankin EB, Rha J, Unger TL, Wu CH, Shutt
HP, Johnson RS, Simon MC, Keith B and Haase VH: Hypoxia-inducible
factor-2 regulates vascular tumorigenesis in mice. Oncogene.
27:5354–5358. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Copple BL, Bai S and Moon JO:
Hypoxia-inducible factor-dependent production of profibrotic
mediators by hypoxic Kupffer cells. Hepatol Res. 40:530–539. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wykoff CC, Sotiriou C, Cockman ME,
Ratcliffe PJ, Maxwell P, Liu E and Harris AL: Gene array of VHL
mutation and hypoxia shows novel hypoxia-induced genes and that
cyclin D1 is a VHL target gene. Br J Cancer. 90:1235–1243. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu W, Xin H, Eckert DT, Brown JA and
Gnarra JR: Hypoxia and cell cycle regulation of the von
Hippel-Lindau tumor suppressor. Oncogene. 30:21–31. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao S, Jin C, Zhao X, Jin B, Hui L, Zhou
W, Niu G and Tao S: Expression and clinical significance of ING4
and HIF-1 alpha in brain astrocytoma. Zhonghua Yi Xue Za Zhi.
95:3533–3536. 2015.(In Chinese). PubMed/NCBI
|
|
9
|
Burrows N, Babur M, Resch J, Williams KJ
and Brabant G: Hypoxia-inducible factor in thyroid carcinoma. J
Thyroid Res. 2011:7629052011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trisciuoglio D, Gabellini C, Desideri M,
Ziparo E, Zupi G and Del Bufalo D: Bcl-2 regulates HIF-1α protein
stabilization in hypoxic melanoma cells via the molecular chaperone
HSP90. PLoS One. 5:e117722010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mardilovich K and Shaw LM: Hypoxia
regulates insulin receptor substrate-2 expression to promote breast
carcinoma cell survival and invasion. Cancer Res. 69:8894–8901.
2009.10.1158/0008-5472.CAN-09-1152. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Raval RR, Lau KW, Tran MGB, Sowter HM,
Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL and Ratcliffe
PJ: Contrasting properties of hypoxia-inducible factor 1 (HIF-1)
and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol
Cell Biol. 25:5675–5686. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mazumdar J, Hickey MM, Pant DK, Durham AC,
Sweet-Cordero A, Vachani A, Jacks T, Chodosh LA, Kissil JL, Simon
MC and Keith B: HIF-2α deletion promotes Kras-driven lung tumor
development. Proc Natl Acad Sci USA. 107:14182–14187. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Florczyk U, Czauderna S, Stachurska A,
Tertil M, Nowak W, Kozakowska M, Poellinger L, Jozkowicz A, Loboda
A and Dulak J: Opposite effects of HIF-1α and HIF-2α on the
regulation of IL-8 expression in endothelial cells. Free Radic Biol
Med. 1:1882–1892. 2011. View Article : Google Scholar
|
|
15
|
Rankin EB, Rha J, Selak MA, Unger TL,
Keith B, Liu Q and Haase VH: Hypoxia-inducible factor 2 regulates
hepatic lipid metabolism. Mol Cell Biol. 29:4527–4538. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Choi YK, Kim CK, Lee H, Jeoung D, Ha KS,
Kwon YG, Kim KW and Kim YM: Carbon monoxide promotes VEGF
expression by increasing HIF-1α protein level via two distinct
mechanisms, translational activation and stabilization of HIF-1α
protein. J Biol Chem. 285:32116–32125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kapitsinou PP, Liu Q, Unger TL, Rha J,
Davidoff O, Keith B, Epstein JA, Moores SL, Erickson-Miller CL and
Haase VH: Hepatic HIF-2 regulates erythropoietic responses to
hypoxia in renal anemia. Blood. 116:3039–3048. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rankin EB, Biju MP, Liu Q, Unger TL, Rha
J, Johnson RS, Simon MC, Keith B and Haase VH: Hypoxia-inducible
factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin
Invest. 117:1068–1077. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei K, Piecewicz SM, McGinnis LM,
Taniguchi CM, Wiegand SJ, Anderson K, Chan CW, Mulligan KX, Kuo D,
Yuan J, et al: A liver Hif-2α-Irs2 pathway sensitizes hepatic
insulin signaling and is modulated by Vegf inhibition. Nat Med.
19:1331–1337. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qiu Y, Zheng H, Sun LH, Peng K, Xiao WD
and Yang H: Hypoxia-inducible factor-1 modulates upregulation of
mutT homolog-1 in colorectal cancer. World J Gastroenterol.
21:13447–13456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukasawa T, Enomoto A and Miyagawa K:
Serine-Threonine Kinase 38 regulates CDC25A stability and the DNA
damage-induced G2/M checkpoint. Cell Signal. 27:1569–1575. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meade ES, Ma YY and Guller S: Role of
hypoxia-inducible transcription factors 1α and 2α in the regulation
of plasminogen activator inhibitor-1 expression in a human
trophoblast cell line. Placenta. 28:1012–1019. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li N, Wang HX, Zhang A, Ye YP and He GY:
KISS-1 inhibits the proliferation and invasion of gastric carcinoma
cells. World J Gastroenterol. 18:1827–1833. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Semenza GL: Defining the role of
hypoxia-inducible factor 1 in cancer biology and therapeutics.
Oncogene. 29:625–634. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bensellam M, Duvillié B, Rybachuk G,
Laybutt DR, Magnan C, Guiot Y, Pouysségur J and Jonas JC:
Glucose-induced O2 consumption activates hypoxia
inducible factors 1 and 2 in rat insulin-secreting pancreatic
beta-cells. PLoS One. 7:e298072012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jing SW, Wang YD, Kuroda M, Su JW, Sun GG,
Liu Q, Cheng YJ and Yang CR: HIF-1α contributes to hypoxia-induced
invasion and metastasis of esophageal carcinoma via inhibiting
E-cadherin and promoting MMP-2 expression. Acta Med Okayama.
66:399–407. 2012.PubMed/NCBI
|
|
27
|
Leonard MO, Howell K, Madden SF, Costello
CM, Higgins DG, Taylor CT and McLoughlin P: Hypoxia selectively
activates the CREB family of transcription factors in the in vivo
lung. Am J Respir Crit Care Med. 178:977–983. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gordan JD, Bertout JA, Hu CJ, Diehl JA and
Simon MC: HIF-2α promotes hypoxic cell proliferation by enhancing
c-myc transcriptional activity. Cancer Cell. 11:335–347. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang KT, Takano EA, Mikeska T, Byrne DJ,
Dobrovic A and Fox SB: Aberrant DNA methylation but not mutation of
CITED4 is associated with alteration of HIF-regulated genes in
breast cancer. Breast Cancer Res Treat. 130:319–329. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li N, Wang HX, Qin C, Wang XH and Han FY:
Relationship between clinicopathological features and HIF-2α in
gastric adenocarcinoma. Genet Mol Res. 14:1404–1413. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xiao H, Gu Z, Wang G and Zhao T: The
possible mechanisms underlying the impairment of HIF-1α pathway
signaling in hyperglycemia and the beneficial effects of certain
therapies. Int J Med Sci. 10:1412–1421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yokoe S, Nakagawa T, Kojima Y, Higuchi K
and Asahi M: Indomethacin-induced intestinal epithelial cell damage
is mediated by pVHL activation through the degradation of collagen
I and HIF-1α. Biochem Biophys Res Commun. 468:671–676. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu P, Ning Y, Yao L, Chen M and Xu C: The
proliferation, apoptosis, invasion of endothelial-like epithelial
ovarian cancer cells induced by hypoxia. J Exp Clin Cancer Res.
29:1242010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yoo HI, Moon YH and Kim MS: Effects of
CoCl2 on multi-lineage differentiation of C3H/10T1/2 mesenchymal
stem cells. Korean J Physiol Pharmacol. 20:53–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang Q, Peng K and He L: Expression of the
HIF-2α in epithelial ovarian cancer and clinical significance.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 39:889–893. 2014.PubMed/NCBI
|
|
36
|
Anelli V, Gault CR, Cheng AB and Obeid LM:
Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma
cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem.
283:3365–3375. 2008. View Article : Google Scholar : PubMed/NCBI
|
